Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-038072 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
320,627
Total Value
$126,530.86
P&L
+inf% (+$5,368,363.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 2, 2026 | Grant/Award | 44,330 | $0.00 | $0.00 | 194,614 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 3, 2026 | Sale | 10,204 | $12.26 | $125,073.49 | 184,410 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Feb 3, 2026 | Sale | 113 | $12.90 | $1,457.37 | 184,297 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 265,980 | $0.00 | $0.00 | 265,980 | Direct | โ | View Details |